Skip to main content
. 2019 Jan 10;19(3):2077–2086. doi: 10.3892/mmr.2019.9843

Table II.

Expression levels of flTF and asTF in cell lines and tissues.

flTF asTF


Cell lines and tissues Group Expression levels P-value Expression levels P-value
Caco-2 ApoM OE group 4.73×10−4±6.22×10−5 0.66 2.29×10−4±4.53×10−5 0.03a
Control group 4.23×10−4±9.22×10−5 1.19×10−4±1.27×10−5
EA.hy926 ApoM OE group 1.40×10−4±1.43×10−5 0.24 4.17×10−5±8.43×10−6 0.82
Control group 1.59×10−4±3.86×10−6 4.50×10−5±1.14×10−5
HepG2 cells CDCA group 4.20×10−4±4.53×10−5 0.04a 1.23×10−4±1.48×10−5 0.42
Control group 3.02×10−4±2.34×10−5 1.07×10−4±1.11×10−5
NSCLC Normal tissues 0.034±0.034 0.97 0.005±0.008 0.54
Adjacent tissues 0.052±0.067 0.011±0.016
Tumor tissues 0.040±0.041 0.008±0.015
Cervical cancer Normal tissues 0.007±0.006 0.62 0.0003±0.0004 0.001a
Tumor tissues 0.007±0.007 0.002±0.002
a

Statistically significant difference. ApoM, apolipoprotein M; asTF, alternatively spliced TF; CDCA, chenodeoxycholic acid; flTF, full-length TF; NSCL, non-small cell lung cancer; OE, overexpression; TF, tissue factor.